45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
13,983
Insurances with rates
23
CPT / HCPCS codes
9,054
Source MRF
Most expensive procedures (gross)
66658-510-01
$2,026
EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION
Gross
$101,310
50881-012-10
$31,500
AXATILIMAB-CSFR 50 MG/ML INTRAVENOUS SOLUTION
Gross
$78,750
58468-0200-1
$24,541
ALEMTUZUMAB 12 MG/1.2 ML INTRAVENOUS SOLUTION
Gross
$73,624
72694-515-01
$5,807
CALASPARGASE PEGOL-MKNL 750 UNIT/ML INTRAVENOUS SOLUTION
Gross
$72,590
82705-010-01
$24,236
EPCORITAMAB-BYSP 48 MG/0.8 ML SUBCUTANEOUS SOLUTION
Gross
$48,471
66658-505-01
$1,816
EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION
Gross
$45,395
57894-650-02
$874
GUSELKUMAB 200 MG/20 ML (10 MG/ML) INTRAVENOUS SOLUTION
Gross
$43,699
0024-5823-15
$15,031
CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION
Gross
$37,577
51144-050-01
$14,640
BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION
Gross
$36,600
0173-0898-03
$1,415
DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION
Gross
$35,383
50881-023-11
$31,500
AXATILIMAB-CSFR 50 MG/ML INTRAVENOUS SOLUTION
Gross
$34,650
50242-917-01
$675
ATEZOLIZUMAB 1 200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION
Gross
$33,755
61755-008-01
$1,873
CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION
Gross
$32,775
68727-745-01
$12,921
DAUNORUBICIN 44 MG AND CYTARABINE 100 MG IN LIPOSOME IV SOLUTION
Gross
$32,303
57894-503-01
$846
DARATUMUMAB 1 800 MG-HYALURONIDASE-FIHJ 30 000 UNIT/15 ML SUBCUT SOLN
Gross
$31,716
50242-127-01
$1,263
GLOFITAMAB-GXBM 1 MG/ML INTRAVENOUS SOLUTION
Gross
$31,577
0008-4510-01
$12,054
GEMTUZUMAB OZOGAMICIN 4.5 MG (1 MG/ML INITIAL CONCENTRATION) IV SOLN
Gross
$30,135
0173-0896-01
$10,592
BELANTAMAB MAFODOTIN-BLMF 100 MG INTRAVENOUS SOLUTION
Gross
$26,479
50242-085-27
$10,560
ALTEPLASE 100 MG INTRAVENOUS SOLUTION
Gross
$26,401
50242-085-25
$10,560
ALTEPLASE INFUSION - PE
Gross
$26,401
58468-0225-1
$10,286
CAPLACIZUMAB-YHDP 11 MG INJECTION KIT
Gross
$25,715
58468-0227-1
$10,286
CAPLACIZUMAB-YHDP 11 MG SOLUTION FOR INJECTION
Gross
$25,715
50242-918-01
$630
ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) INTRAVENOUS SOLUTION
Gross
$22,054
25682-001-01
$261
ECULIZUMAB 300 MG/30 ML INTRAVENOUS SOLUTION
Gross
$19,569
50242-087-01
$7,660
ADO-TRASTUZUMAB EMTANSINE 160 MG INTRAVENOUS SOLUTION
Gross
$19,150
73475-3041-5
$371
EFGARTIGIMOD ALFA-FCAB 20 MG/ML INTRAVENOUS SOLUTION
Gross
$18,571
76310-022-01
$6,662
ALDESLEUKIN 22 MILLION UNIT INTRAVENOUS SOLUTION
Gross
$16,654
73607-002-01
$6,454
ARTESUNATE 110 MG INTRAVENOUS SOLUTION
Gross
$16,136
73607-011-11
$6,454
ARTESUNATE 110 MG INTRAVENOUS SOLUTION
Gross
$16,136
0310-3040-00
$3,200
ANIFROLUMAB-FNIA 300 MG/2 ML (150 MG/ML) INTRAVENOUS SOLUTION
Gross
$16,002
68727-900-01
$12,560
ASPARAGINASE ERWINIA CHRYSANTHEMI-RYWN 10 MG/0.5 ML IM SOLUTION
Gross
$15,700
50419-385-01
$6,180
COPANLISIB 60 MG INTRAVENOUS SOLUTION
Gross
$15,451
50633-120-11
$5,969
DIGOXIN IMMUNE FAB 40 MG INTRAVENOUS SOLUTION
Gross
$14,922
65597-801-01
$5,869
DATOPOTAMAB DERUXTECAN-DLNK 100 MG INTRAVENOUS SOLUTION
Gross
$14,673
50242-044-13
$5,280
ALTEPLASE 50 MG INTRAVENOUS SOLUTION
Gross
$13,201
50242-044-06
$5,280
ALTEPLASE INFUSION - PE (CARDIAC ARREST)
Gross
$13,201
63833-835-01
$5,126
C1 ESTERASE INHIBITOR 500 UNIT (10 ML) INTRAVENOUS SOLUTION
Gross
$12,815
51144-030-01
$5,056
ENFORTUMAB VEDOTIN-EJFV 30 MG INTRAVENOUS SOLUTION
Gross
$12,641
0310-4611-50
$505
DURVALUMAB 50 MG/ML INTRAVENOUS SOLUTION
Gross
$12,631
50242-088-01
$4,788
ADO-TRASTUZUMAB EMTANSINE 100 MG INTRAVENOUS SOLUTION
Gross
$11,969
55513-032-01
$4,644
DARBEPOETIN ALFA 500 MCG/ML IN POLYSORBATE INJECTION SYRINGE
Gross
$11,610
65757-404-03
$1,181
ARIPIPRAZOLE LAUROXIL ER 1 064 MG/3.9 ML SUSPENSION EXT.REL IM SYRINGE
Gross
$11,516
57894-501-00
$653
AMIVANTAMAB-VMJW 50 MG/ML INTRAVENOUS SOLUTION
Gross
$11,420
0006-3025-00
$114
BEZLOTOXUMAB 25 MG/ML INTRAVENOUS SOLUTION
Gross
$11,400
42023-157-01
$4,560
ETHACRYNATE SODIUM 50 MG INTRAVENOUS SOLUTION
Gross
$11,400
67457-297-50
$4,560
ETHACRYNATE SODIUM 50 MG INTRAVENOUS SOLUTION
Gross
$11,400
0024-5860-01
$214
CLOFARABINE 1 MG/ML INTRAVENOUS SOLUTION
Gross
$10,693
76075-101-01
$4,245
CARFILZOMIB 60 MG INTRAVENOUS SOLUTION
Gross
$10,612
73594-9310-1
$421
FERRIC DERISOMALTOSE 100 MG IRON/ML INTRAVENOUS SOLUTION
Gross
$10,535
55513-730-01
$2,435
DENOSUMAB 120 MG/1.7 ML (70 MG/ML) SUBCUTANEOUS SOLUTION
Gross
$10,349
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 66658-510-01 | EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION | $101,310 | $2,026 | — | — | 0 |
| 50881-012-10 | AXATILIMAB-CSFR 50 MG/ML INTRAVENOUS SOLUTION | $78,750 | $31,500 | — | — | 0 |
| 58468-0200-1 | ALEMTUZUMAB 12 MG/1.2 ML INTRAVENOUS SOLUTION | $73,624 | $24,541 | — | — | 0 |
| 72694-515-01 | CALASPARGASE PEGOL-MKNL 750 UNIT/ML INTRAVENOUS SOLUTION | $72,590 | $5,807 | — | — | 0 |
| 82705-010-01 | EPCORITAMAB-BYSP 48 MG/0.8 ML SUBCUTANEOUS SOLUTION | $48,471 | $24,236 | — | — | 0 |
| 66658-505-01 | EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION | $45,395 | $1,816 | — | — | 0 |
| 57894-650-02 | GUSELKUMAB 200 MG/20 ML (10 MG/ML) INTRAVENOUS SOLUTION | $43,699 | $874 | — | — | 0 |
| 0024-5823-15 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $37,577 | $15,031 | — | — | 0 |
| 51144-050-01 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $36,600 | $14,640 | — | — | 0 |
| 0173-0898-03 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION | $35,383 | $1,415 | — | — | 0 |
| 50881-023-11 | AXATILIMAB-CSFR 50 MG/ML INTRAVENOUS SOLUTION | $34,650 | $31,500 | — | — | 0 |
| 50242-917-01 | ATEZOLIZUMAB 1 200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION | $33,755 | $675 | — | — | 0 |
| 61755-008-01 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION | $32,775 | $1,873 | — | — | 0 |
| 68727-745-01 | DAUNORUBICIN 44 MG AND CYTARABINE 100 MG IN LIPOSOME IV SOLUTION | $32,303 | $12,921 | — | — | 0 |
| 57894-503-01 | DARATUMUMAB 1 800 MG-HYALURONIDASE-FIHJ 30 000 UNIT/15 ML SUBCUT SOLN | $31,716 | $846 | — | — | 0 |
| 50242-127-01 | GLOFITAMAB-GXBM 1 MG/ML INTRAVENOUS SOLUTION | $31,577 | $1,263 | — | — | 0 |
| 0008-4510-01 | GEMTUZUMAB OZOGAMICIN 4.5 MG (1 MG/ML INITIAL CONCENTRATION) IV SOLN | $30,135 | $12,054 | — | — | 0 |
| 0173-0896-01 | BELANTAMAB MAFODOTIN-BLMF 100 MG INTRAVENOUS SOLUTION | $26,479 | $10,592 | — | — | 0 |
| 50242-085-27 | ALTEPLASE 100 MG INTRAVENOUS SOLUTION | $26,401 | $10,560 | — | — | 0 |
| 50242-085-25 | ALTEPLASE INFUSION - PE | $26,401 | $10,560 | — | — | 0 |
| 58468-0225-1 | CAPLACIZUMAB-YHDP 11 MG INJECTION KIT | $25,715 | $10,286 | — | — | 0 |
| 58468-0227-1 | CAPLACIZUMAB-YHDP 11 MG SOLUTION FOR INJECTION | $25,715 | $10,286 | — | — | 0 |
| 50242-918-01 | ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) INTRAVENOUS SOLUTION | $22,054 | $630 | — | — | 0 |
| 25682-001-01 | ECULIZUMAB 300 MG/30 ML INTRAVENOUS SOLUTION | $19,569 | $261 | — | — | 0 |
| 50242-087-01 | ADO-TRASTUZUMAB EMTANSINE 160 MG INTRAVENOUS SOLUTION | $19,150 | $7,660 | — | — | 0 |
| 73475-3041-5 | EFGARTIGIMOD ALFA-FCAB 20 MG/ML INTRAVENOUS SOLUTION | $18,571 | $371 | — | — | 0 |
| 76310-022-01 | ALDESLEUKIN 22 MILLION UNIT INTRAVENOUS SOLUTION | $16,654 | $6,662 | — | — | 0 |
| 73607-002-01 | ARTESUNATE 110 MG INTRAVENOUS SOLUTION | $16,136 | $6,454 | — | — | 0 |
| 73607-011-11 | ARTESUNATE 110 MG INTRAVENOUS SOLUTION | $16,136 | $6,454 | — | — | 0 |
| 0310-3040-00 | ANIFROLUMAB-FNIA 300 MG/2 ML (150 MG/ML) INTRAVENOUS SOLUTION | $16,002 | $3,200 | — | — | 0 |
| 68727-900-01 | ASPARAGINASE ERWINIA CHRYSANTHEMI-RYWN 10 MG/0.5 ML IM SOLUTION | $15,700 | $12,560 | — | — | 0 |
| 50419-385-01 | COPANLISIB 60 MG INTRAVENOUS SOLUTION | $15,451 | $6,180 | — | — | 0 |
| 50633-120-11 | DIGOXIN IMMUNE FAB 40 MG INTRAVENOUS SOLUTION | $14,922 | $5,969 | — | — | 0 |
| 65597-801-01 | DATOPOTAMAB DERUXTECAN-DLNK 100 MG INTRAVENOUS SOLUTION | $14,673 | $5,869 | — | — | 0 |
| 50242-044-13 | ALTEPLASE 50 MG INTRAVENOUS SOLUTION | $13,201 | $5,280 | — | — | 0 |
| 50242-044-06 | ALTEPLASE INFUSION - PE (CARDIAC ARREST) | $13,201 | $5,280 | — | — | 0 |
| 63833-835-01 | C1 ESTERASE INHIBITOR 500 UNIT (10 ML) INTRAVENOUS SOLUTION | $12,815 | $5,126 | — | — | 0 |
| 51144-030-01 | ENFORTUMAB VEDOTIN-EJFV 30 MG INTRAVENOUS SOLUTION | $12,641 | $5,056 | — | — | 0 |
| 0310-4611-50 | DURVALUMAB 50 MG/ML INTRAVENOUS SOLUTION | $12,631 | $505 | — | — | 0 |
| 50242-088-01 | ADO-TRASTUZUMAB EMTANSINE 100 MG INTRAVENOUS SOLUTION | $11,969 | $4,788 | — | — | 0 |
| 55513-032-01 | DARBEPOETIN ALFA 500 MCG/ML IN POLYSORBATE INJECTION SYRINGE | $11,610 | $4,644 | — | — | 0 |
| 65757-404-03 | ARIPIPRAZOLE LAUROXIL ER 1 064 MG/3.9 ML SUSPENSION EXT.REL IM SYRINGE | $11,516 | $1,181 | — | — | 0 |
| 57894-501-00 | AMIVANTAMAB-VMJW 50 MG/ML INTRAVENOUS SOLUTION | $11,420 | $653 | — | — | 0 |
| 0006-3025-00 | BEZLOTOXUMAB 25 MG/ML INTRAVENOUS SOLUTION | $11,400 | $114 | — | — | 0 |
| 42023-157-01 | ETHACRYNATE SODIUM 50 MG INTRAVENOUS SOLUTION | $11,400 | $4,560 | — | — | 0 |
| 67457-297-50 | ETHACRYNATE SODIUM 50 MG INTRAVENOUS SOLUTION | $11,400 | $4,560 | — | — | 0 |
| 0024-5860-01 | CLOFARABINE 1 MG/ML INTRAVENOUS SOLUTION | $10,693 | $214 | — | — | 0 |
| 76075-101-01 | CARFILZOMIB 60 MG INTRAVENOUS SOLUTION | $10,612 | $4,245 | — | — | 0 |
| 73594-9310-1 | FERRIC DERISOMALTOSE 100 MG IRON/ML INTRAVENOUS SOLUTION | $10,535 | $421 | — | — | 0 |
| 55513-730-01 | DENOSUMAB 120 MG/1.7 ML (70 MG/ML) SUBCUTANEOUS SOLUTION | $10,349 | $2,435 | — | — | 0 |
Showing top 50 of 13,983 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.